Oil prices hold sharp losses with focus on secondary India tariffs
Director Rhea J. Posedel of Aehr Test Systems (NASDAQ:AEHR), a company with a market capitalization of $638 million and a notable year-to-date return of 28%, sold 18,000 shares of common stock on July 22, 2025, at a price of $19.8318, for a total value of $356,972. According to InvestingPro data, the stock has shown significant volatility with a beta of 2.3.
On the same day, Posedel also exercised options to acquire 18,000 shares of Aehr Test Systems common stock at an exercise price of $2.4, for a total value of $43,200.
Following the sale, Posedel directly owns 71,163 shares of Aehr Test Systems, which includes shares subject to unvested restricted stock units. Posedel also indirectly owns 470,977 shares by trust.
In other recent news, Aehr Test Systems announced the receipt of follow-on orders from a major hyperscaler customer for eight Sonoma ultra-high-power systems. These systems are intended for the volume production testing and burn-in of AI processors and will be shipped over the next six months. This development represents more than a doubling of production systems with the customer, signaling a significant expansion of their existing relationship. On the financial front, Aehr Test Systems reported a decline in fiscal fourth-quarter revenue to $14.1 million, down from $16.6 million in the same period last year. The company also reported a net loss of $2.9 million, contrasting with the GAAP net income of $23.9 million in the previous fiscal year’s same quarter. Despite missing revenue expectations, Aehr met earnings per share forecasts, with revenue falling short by 4.73% against a $14.8 million forecast. While the revenue dip was notable, the company’s strategic initiatives may have contributed to some investor optimism. These developments highlight Aehr Test Systems’ ongoing adjustments and expansions in the semiconductor equipment market.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.